Turbine was founded for a simple reason; to understand complex cancers better than existing experimental tools in order to solve unmet oncology needs. Through a multidisciplinary team that unites computer science and molecular biology, and the world’s most intricate simulation of cell behavior, the company identifies treatment options for the 70% of cancers that are currently unexplored. Through their platform, the Simulated Cell™, they uncover novel biological insights across both new and known targets. This allows them to provide a fresh biological context, define responsive patient populations, and design drug combination approaches that diminish resistance.
